TPD52L2 as a potential prognostic and immunotherapy biomarker in clear cell renal cell carcinoma

TPD52L2 as a potential prognostic and immunotherapy biomarker in clear cell renal cell carcinoma

BackgroundTumor Protein D52-Like 2 (TPD52L2) is a tumor-associated protein that participates in B-cell differentiation. However, the role of TPD52L2 in the pathological process of clear cell renal cell carcinoma (ccRCC) is unclear.MethodsMultiple omics data of ccRCC samples were obtained from public...

Full description

Bibliographic Details
Main Authors: Hongbo Wang, Zhendong Liu, Yuelin Du, Xingbo Cheng, Shanjun Gao, Yanzheng Gao, Panfeng Shang
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-11-01
Series:Frontiers in Oncology
Subjects:
clear cell renal cell carcinoma
TPD52 Like 2
prognosis
tumor microenvironment
malignant phenotype
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1210910/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2023.1210910/full

Similar Items